trial
as of 2026-07-01Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia
NCTId NCT02013622
at a glance
Phase 3 · Completed
Enrollment 49 (actual)
Primary completion 2014-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Completed
Enrollment
49 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2013-11
Primary completion
2014-09
Eligibility
ALL · 18 Years · 35 Years
Interventions & indications
Sponsors
Investigators
1
Jun-ichi Hashimoto, PhDStudy Director
Sites
0 total
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
49
Phase
PHASE3
Primary Completion Date
2014-09
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator
person